EverHealth Scribe
Search documents
EverCommerce(EVCM) - 2025 Q4 - Earnings Call Transcript
2026-03-12 22:02
Financial Data and Key Metrics Changes - In Q4 2025, EverCommerce generated revenue of $151.2 million, representing a 5.2% year-over-year growth [6][20] - Adjusted EBITDA for the quarter was $44.2 million, with a margin of 29.2%, reflecting operational discipline and efficiency improvements [21][22] - Pro forma revenue for the last twelve months was $591.7 million, indicating a 6.4% year-over-year growth [8][20] Business Line Data and Key Metrics Changes - EverPro and EverHealth verticals accounted for approximately 95% of consolidated revenue, with significant investments in AI capabilities [7][11] - Multi-solution customers grew by 26% year-over-year, with 286,000 customers enabled for more than one solution [16] - The top six payment solutions experienced a 17.4% year-over-year growth in total payment volume [17] Market Data and Key Metrics Changes - The annualized total payments volume expanded to $13 billion, showcasing the growth potential in the payments segment [8] - The company reported a net revenue retention rate of 96%, with multi-solution customers generating NRR above 100% [17] Company Strategy and Development Direction - The company is focused on embedding AI across its platforms to enhance customer experiences and operational efficiency [63] - Investments in AI-driven features and workflows are expected to drive durable growth and improve cash flow generation [26][63] - The acquisition of ZyraTalk is seen as a foundational step towards building an agentic platform for enhanced customer engagement [10][32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the growth prospects for 2026, driven by AI investments and improved customer engagement strategies [36][58] - The company anticipates continued operational improvements and a focus on delivering enhanced customer experiences through AI [63] Other Important Information - The company repurchased approximately 2.5 million shares for $24.8 million in Q4 2025, reflecting a commitment to returning value to shareholders [25] - The leadership update included Matt Feierstein taking on the role of CEO for EverPro, emphasizing continuity in strategy execution [18] Q&A Session Summary Question: Customer appetite for AI solutions - Management noted strong uptake in AI functionalities across EverPro, with positive early sales from ZyraTalk integrations [30][31] Question: 2026 growth outlook assumptions - The growth outlook is supported by investments in AI and expectations of re-acceleration in revenue through the year [36][39] Question: Payments revenue decline explanation - The decline in non-top six payment solutions was not significantly related to the MarTech divestiture, with focus on mature and growth segments of the portfolio [42][44] Question: Competitive advantages in the AI landscape - Management highlighted deep niche vertical expertise and a large customer base as key advantages in adapting to AI advancements [45][47] Question: Incremental revenue from no-show prediction tool - The no-show prediction tool is included in packages, with expectations of increased overall ASP as new features are added [51]
EverCommerce(EVCM) - 2025 Q4 - Earnings Call Transcript
2026-03-12 22:02
EverCommerce (NasdaqGS:EVCM) Q4 2025 Earnings call March 12, 2026 05:00 PM ET Company ParticipantsAaron Kimson - VPBrad Korch - SVP and Head of Investor RelationsEric Remer - CEOEvan Berlin - CEOMatt Feierstein - PresidentRyan Siurek - CFONone - Company RepresentativeConference Call ParticipantsAlex Sklar - AnalystDan Bergstrom - AnalystOperatorAs a reminder, this conference call is being recorded today, March 12th, 2026. I would now like to turn the conference over to Brad Korch, SVP Finance and Head of In ...
EverCommerce(EVCM) - 2025 Q4 - Earnings Call Transcript
2026-03-12 22:00
EverCommerce (NasdaqGS:EVCM) Q4 2025 Earnings call March 12, 2026 05:00 PM ET Speaker8As a reminder, this conference call is being recorded today, March twelfth, two thousand and twenty-six. I would now like to turn the conference over to Brad Korch, SVP Finance and Head of Investor Relations for EverCommerce. Please go ahead.Speaker3Good afternoon, and thank you for joining. Today's call will be led by Eric Remer, EverCommerce's Chairman and Chief Executive Officer, and Ryan Siurek, EverCommerce's Chief Fi ...
Why EverCommerce’s (EVCM) Latest Update Was an Insider Sale, Not an Operating Shift
Yahoo Finance· 2026-03-12 16:14
Company Overview - EverCommerce Inc. (NASDAQ:EVCM) is a service commerce platform providing vertically tailored SaaS solutions to service-based businesses, serving over 725,000 global service SMBs across various categories including home, health, and wellness [3]. Recent Developments - On March 10, EverCommerce announced the launch of EverHealth Scribe, an AI-powered technology integrated into the DrChrono electronic health record platform, which automates the generation of structured visit notes from provider-patient conversations, enhancing documentation efficiency for clinicians [1]. - CEO Evan Berlin emphasized that this launch demonstrates the company's commitment to delivering smarter, AI-driven solutions aimed at improving provider and patient outcomes [1]. Insider Transactions - On March 4 and March 5, 2026, EverCommerce President Matthew David Feierstein sold a total of 15,000 shares for $181,169, with share prices ranging from $12.0304 to $12.173 [1]. - The transactions were executed under a prearranged Rule 10b5-1 trading plan established on August 20, 2025, indicating that these sales were planned in advance rather than in response to immediate company developments [2]. - Following these sales, Feierstein retained direct ownership of 1,980,589 shares and indirect ownership of 150,000 shares through a family trust, maintaining a significant stake in the company [2].
DrChrono Expands AI Capabilities with Launch of EverHealth Scribe Ambient Documentation Solution
Globenewswire· 2026-03-10 13:15
Core Insights - EverHealth has launched EverHealth Scribe, an AI-powered ambient documentation technology integrated into the DrChrono EHR platform, aimed at reducing clinical documentation burdens for healthcare providers [1][2][3] - The technology allows for automatic generation of structured visit notes from provider-patient conversations, enhancing efficiency and compliance in documentation [1][3] Group 1: Product Features and Benefits - EverHealth Scribe users report an average savings of 8 minutes in clinical documentation time per visit, which allows providers to close charts faster and reduce after-hours work [3] - The implementation of EverHealth Scribe has led to a 32% increase in same-day claim submissions, positively impacting revenue cycle performance and cash flow predictability for practices [3] Group 2: Strategic Partnerships and Future Developments - EverHealth has formed a strategic AI partnership with CarePilot to enhance the delivery of AI experiences within the DrChrono platform, focusing on reducing administrative burdens and improving clinical efficiency [2] - The Chief Technology Officer of EverHealth emphasized that EverHealth Scribe is a foundational step for ongoing AI innovation in documentation and clinical workflows within the DrChrono platform [3] Group 3: Company Overview - EverCommerce, the parent company of EverHealth, is a leading service commerce platform that provides integrated SaaS solutions to over 725,000 service-based businesses globally, aiming to accelerate growth and streamline operations [5]